Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Black Diamond Therapeutics (BDTX) Assets Average (2020 - 2025)

Black Diamond Therapeutics (BDTX) has disclosed Assets Average for 2 consecutive years, with $281.0 million as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Assets Average fell 19.24% year-over-year to $281.0 million, compared with a TTM value of $281.0 million through Sep 2021, down 19.24%, and an annual FY2020 reading of $244.0 million, changed N/A over the prior year.
  • Assets Average was $281.0 million for Q3 2021 at Black Diamond Therapeutics, down from $300.6 million in the prior quarter.
  • Across five years, Assets Average topped out at $356.1 million in Q2 2020 and bottomed at $260.5 million in Q1 2020.